Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12569700 | Methods of use of ultra-high dose rate radiation and therapeutic agent | 🖼🧊📄§ | 2026-03-10 | 2043-08-24 | 0 | 31 |
| 12570715 | T cell receptors and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-07-29 | 0 | 31 |
| 12569463 | Method for treating diabetes | 🖼🧊📄§ | 2026-03-10 | 2042-09-22 | 0 | 31 |
| 12570767 | Sequences of anti-ecto-5′-nucleotidase antibodies | 🖼🧊📄§ | 2026-03-10 | 2042-05-27 | 0 | 31 |
| 12569497 | Use of HCN inhibitors for treatment of cancer | 🖼🧊📄§ | 2026-03-10 | 2038-04-25 | 0 | 31 |
| 12569509 | Method and composition for preventing and treating viral infections | 🖼🧊📄§ | 2026-03-10 | 2042-04-26 | 0 | 31 |
| 12569482 | Methods and compositions for treating idiopathic pulmonary fibrosis | 🖼🧊📄§ | 2026-03-10 | 2040-10-02 | 0 | 31 |
| 12570740 | Treatment for physiological iron overload with an anti-matriptase-2 antibody | 🖼🧊📄§ | 2026-03-10 | 2040-11-27 | 0 | 31 |
| 12569439 | Bottom-up assembly of synthetic extracellular vesicles | 🖼🧊📄§ | 2026-03-10 | 2041-01-29 | 0 | 31 |
| 12569536 | Macrocyclic peptides for targeted inhibition of autophagy | 🖼🧊📄§ | 2026-03-10 | 2040-01-30 | 0 | 31 |
| 12570719 | Chimeric antigen receptor comprising anti c-met antibody or antigen binding fragment thereof, and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-09-25 | 0 | 31 |
| 12570980 | Methods and compositions for treating inflammatory conditions associated with infectious disease | 🖼🧊📄§ | 2026-03-10 | 2045-04-02 | 0 | 31 |
| 12569552 | Fusion protein of pentamer and gB of cytomegalovirus, and vaccine containing said fusion protein | 🖼🧊📄§ | 2026-03-10 | 2041-06-08 | 0 | 31 |
| 12570673 | c-Myc protein inhibitor, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-07-03 | 0 | 31 |
| 12569572 | Messenger RNA therapy for the treatment of Friedreich's ataxia | 🖼🧊📄§ | 2026-03-10 | 2040-09-10 | 0 | 31 |
| 12569551 | Modified immunogenic proteins | 🖼🧊📄§ | 2026-03-10 | 2042-10-24 | 0 | 31 |
| 12570713 | High-affinity TCR for recognizing AFP antigen | 🖼🧊📄§ | 2026-03-10 | 2040-03-06 | 0 | 31 |
| 12570725 | ZIKA antibodies and their use | 🖼🧊📄§ | 2026-03-10 | 2040-09-11 | 0 | 31 |
| 12570733 | Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules | 🖼🧊📄§ | 2026-03-10 | 2042-06-30 | 0 | 31 |
| 12570735 | Compositions and methods for treating inflammasome related diseases or conditions | 🖼🧊📄§ | 2026-03-10 | 2039-07-03 | 0 | 31 |
| 12569477 | Compositions for synergistically enhancing mitochondrial function | 🖼🧊📄§ | 2026-03-10 | 2042-12-29 | 0 | 31 |
| 12570738 | Multi-specific antibody with binding specificity for human IL-13 and IL-17 | 🖼🧊📄§ | 2026-03-10 | 2040-12-18 | 0 | 31 |
| 12570720 | Engineered receptors for human cytomegalovirus and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-09-15 | 0 | 31 |
| 12570605 | Indole compounds, and preparation methods, and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-09-02 | 0 | 31 |
| 12569500 | Combination comprising tricycle compound and use thereof in preparation of medicament for treating HBV | 🖼🧊📄§ | 2026-03-10 | 2041-05-14 | 0 | 31 |
| 12570731 | Methods for treating cancer with an anti-apo B100 antibody | 🖼🧊📄§ | 2026-03-10 | 2040-11-12 | 0 | 31 |
| 12569496 | Treatment of cancer with a RAF inhibitor | 🖼🧊📄§ | 2026-03-10 | 2044-01-26 | 0 | 31 |
| 12570759 | Polypeptides | 🖼🧊📄§ | 2026-03-10 | 2039-12-17 | 0 | 31 |
| 12569557 | Targeting moDC to enhance vaccine efficacy on mucosal surface | 🖼🧊📄§ | 2026-03-10 | 2039-09-27 | 0 | 31 |
| 12569455 | Therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome | 🖼🧊📄§ | 2026-03-10 | 2041-02-05 | 0 | 31 |
| 12570714 | Siglec-based chimeric polypeptides and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-04-16 | 0 | 31 |
| 12570608 | Compound derived from quinoline, use of a compound, composition and method for the treatment or prophylaxis of a condition caused by a blood parasite | 🖼🧊📄§ | 2026-03-10 | 2040-09-02 | 0 | 31 |
| 12569521 | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms | 🖼🧊📄§ | 2026-03-10 | 2044-04-22 | 0 | 31 |
| 12570656 | Purine compounds for treating disorders | 🖼🧊📄§ | 2026-03-10 | 2041-03-09 | 0 | 31 |
| 12569430 | Biodegradable implant including naltrexone | 🖼🧊📄§ | 2026-03-10 | 2042-04-01 | 0 | 31 |
| 12570982 | Altering gene expression in modified T cells and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2041-12-14 | 0 | 31 |
| 12570748 | Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2044-06-13 | 0 | 31 |
| 12571796 | Viral exposure signature for detection of early stage hepatocellular carcinoma | 🖼🧊📄§ | 2026-03-10 | 2040-10-09 | 0 | 31 |
| 12570730 | Chimeric antigen receptors for direct and indirect targeting of fibronectin-positive tumors | 🖼🧊📄§ | 2026-03-10 | 2040-07-17 | 0 | 31 |
| 12569530 | Tannin-based antiproliferative pharmaceutical | 🖼🧊📄§ | 2026-03-10 | 2044-04-26 | 0 | 31 |
| 12569484 | Use of phosphodiesterase 5 inhibitor in preparation of medicament for resisting fibrotic diseases | 🖼🧊📄§ | 2026-03-10 | 2040-07-29 | 0 | 31 |
| 12570668 | Single molecule compounds providing multi-target inhibition of BTK and other proteins and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2039-07-22 | 0 | 31 |
| 12569534 | Therapeutic nanoparticles by coacervate complexation and their use for treating bacteria | 🖼🧊📄§ | 2026-03-10 | 2039-07-30 | 0 | 31 |
| 12570614 | Phenyl amino pyrimidine compounds and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-04-20 | 0 | 31 |
| 12570752 | Combination therapy with an anti BCMA antibody and a gamma secretase inhibitor | 🖼🧊📄§ | 2026-03-10 | 2040-04-09 | 0 | 31 |
| 12570973 | Compositions and methods for inhibiting intermediate filament tetramerization | 🖼🧊📄§ | 2026-03-10 | 2039-10-08 | 0 | 31 |
| 12569556 | Aluminum based adjuvants for tolerogenic vaccination | 🖼🧊📄§ | 2026-03-10 | 2041-01-29 | 0 | 31 |
| 12571052 | Immunomodulatory RNA | 🖼🧊📄§ | 2026-03-10 | 2042-05-19 | 0 | 31 |
| 12569540 | Human recombinant hyposialylated erythropoietin, methods of purification and therapeutic uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-02-19 | 0 | 31 |
| 12569549 | Flavivirus vaccine | 🖼🧊📄§ | 2026-03-10 | 2044-01-04 | 0 | 31 |